Fang Shen

Title: The Innovative Contributions of Fang Shen

Introduction

Fang Shen is a notable inventor based in Amherst, NY (US). He has made significant contributions to the field of biotechnology, particularly in the area of immunology. His work focuses on the development of innovative solutions for treating inflammatory and autoimmune diseases.

Latest Patents

Fang Shen holds a patent for the invention titled "Pre-ligand assembly domain of the IL-17 receptor." This invention provides isolated Pre-Ligand Assembly Domain (PLAD) polypeptides that comprise an amino acid sequence of a domain of an IL-17 Receptor (IL-17R) family member. The PLAD polypeptide inhibits the multimerization of a receptor complex comprising an IL-17R family member. Additionally, the patent includes isolated PLAD-binding polypeptides, such as antibodies and avimers, which specifically bind to the described PLAD polypeptide. The invention also outlines methods for treating inflammatory or autoimmune diseases and inhibiting IL-17-mediated signal transduction.

Career Highlights

Fang Shen has worked with prominent organizations, including Amgen Inc. and the State University of New York. His experience in these institutions has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.

Collaborations

Fang has collaborated with notable colleagues, including Sarah L. Gaffen and Walter Hanel. These partnerships have further enhanced his research and innovation in the field of immunology.

Conclusion

Fang Shen's contributions to biotechnology and immunology through his innovative patents and collaborations highlight his role as a significant inventor in the field. His work continues to pave the way for advancements in treating autoimmune diseases.